Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

News & Analysis

China biotech company and industry news and analysis...

Terns Enters $228 Million Agreement with Genfit for NASH Candidate

Sinopharm Leads $20 Million Investment in Singapore's Novena; Plans Joint $150 Million Healthcare Fund

dMed and Target Join to Offer China-US Clinical CRO Services

Eddingpharm In-Licenses Shionogi Thrombocytopenia Treatment

Wuhan's XW Labs Gains US Orphan Drug Status for Narcolepsy Drug

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events


China Showcase 2020

San Francisco, USA

January 12, 2020

ChinaBio Partnering Forum 2020

Suzhou, China

May 6-7, 2020